These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 28247041)

  • 1. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests.
    Sukul P; Schubert JK; Oertel P; Kamysek S; Taunk K; Trefz P; Miekisch W
    Sci Rep; 2016 Jun; 6():28029. PubMed ID: 27311826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of breath VOCs and electrical impedance tomography under pulmonary recruitment in mechanically ventilated patients.
    Brock B; Kamysek S; Silz J; Trefz P; Schubert JK; Miekisch W
    J Breath Res; 2017 Jan; 11(1):016005. PubMed ID: 28068288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
    Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
    J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
    Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
    Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the determination of isoprene in human breath using substrate-integrated hollow waveguide mid-infrared sensors.
    Perez-Guaita D; Kokoric V; Wilk A; Garrigues S; Mizaikoff B
    J Breath Res; 2014 Jun; 8(2):026003. PubMed ID: 24848160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath.
    Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA
    Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atmospheric pressure chemical ionization mass spectrometry of pyridine and isoprene: potential breath exposure and disease biomarkers.
    Kapishon V; Koyanagi GK; Blagojevic V; Bohme DK
    J Breath Res; 2013 Jun; 7(2):026005. PubMed ID: 23579200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study.
    King J; Mochalski P; Kupferthaler A; Unterkofler K; Koc H; Filipiak W; Teschl S; Hinterhuber H; Amann A
    Physiol Meas; 2010 Sep; 31(9):1169-84. PubMed ID: 20664160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of chromatographic breath analysis in the search of volatile biomarkers of chronic kidney disease and coexisting type 2 diabetes mellitus.
    Grabowska-Polanowska B; Skowron M; Miarka P; Pietrzycka A; Śliwka I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():103-110. PubMed ID: 28605624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease.
    Meinardi S; Jin KB; Barletta B; Blake DR; Vaziri ND
    Biochim Biophys Acta; 2013 Mar; 1830(3):2531-7. PubMed ID: 23274524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of volatile organic compounds indicative of human presence in the air.
    Kwak J; Geier BA; Fan M; Gogate SA; Rinehardt SA; Watts BS; Grigsby CC; Ott DK
    J Sep Sci; 2015 Jul; 38(14):2463-9. PubMed ID: 25944350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
    Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
    Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.